Epithelial dysregulation in chronic rhinosinusitis with nasal polyposis (CRSwNP) and aspirin-exacerbated respiratory disease (AERD)
- PMID: 34371082
- PMCID: PMC9271844
- DOI: 10.1016/j.jaci.2021.07.034
Epithelial dysregulation in chronic rhinosinusitis with nasal polyposis (CRSwNP) and aspirin-exacerbated respiratory disease (AERD)
Keywords: Nasal polyposis; airway inflammation; asthma; basal cell; chemosensory cell; epithelial cell.
Conflict of interest statement
Disclosure of Potential Conflicts of Interest:
Dr. Barrett is a consultant for Regeneron and Biohaven Pharmaceuticals
Dr. Cohen is a consultant for Regeneron, Sanofi, GSK, Novartis, Oyster Point Pharma and has a licensing agreement with GeneOne Life Sciences
Dr. Kohanski has no relevant conflicts of interest.
Figures
References
-
- Kristjansson RP, Benonisdottir S, Davidsson OB, Oddsson A, Tragante V, Sigurdsson JK, et al. A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis. Nat Genet. 2019;51(2):267–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
